0.375
price down icon1.06%   -0.004
 
loading

Finanzdaten der Moleculin Biotech Inc-Aktie (MBRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.75%
5.72
5.943 6.643 7.135 6.185
Operating Income/Loss
3.75%
-5.72
-5.943 -6.643 -7.135 -6.185
Income/Loss From Continuing Operations Before Tax
18.71%
-7.64
-6.436 -1.882 -10.59 -4.319
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.71%
-7.64
-6.436 -1.882 -10.59 -4.319
Net Income/Loss
18.71%
-7.64
-6.436 -1.882 -10.59 -4.319
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
66.17%
15.53
9.3438 0.5322 3.7143 2.5432
Basic Earnings Per Share
28.99%
-0.49
-0.69 0.51 -2.85 -1.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):